DEC 23, 2020 11:45 AM PST

Smartphone Device Uses CRISPR to Check for COVID

WRITTEN BY: Tara Fernandes

Quick, portable, and ultrasensitive—a new smartphone test for COVID-19 checks all the boxes needed to get a handle on pandemic control efforts. This is a departure from the lab-based RT-PCR assays that detect viral genomic material in nose or throat swabs that currently represent the gold standard.

The study, published in Science Advances, details how scientists leveraged CRISPR technology to develop the new point-of-care diagnostic device. “This test addresses the critical needs for a rapid, ultrasensitive COVID-19 diagnosis along with effective large-scale screening efforts,” said author Tony Hu, from Tulane University School of Medicine.

This innovation uses CRISPR/Cas12a to enhance the signal from viral RNA after stimulation by a laser diode that sits within a smartphone-based readout device. Results are produced in as little as 15 minutes. In the study, the device was found to be more sensitive than the RT-PCR reference assay. Unlike its lab-based counterpart, the device saved time by doing away with the RNA isolation step. It was also able to sensitively detect SARS-CoV-2 in saliva, which could mean an end to nasal swabs that can be uncomfortable for some patients.

 

 

The device joins an ever-growing list of CRISPR-based diagnostic technologies that have emerged in recent years. CRISPR’s remarkable ability to edit and cleave DNA makes it particularly well-suited for its application in diagnosing viral, bacterial, and even non-infectious diseases such as cancer. Several diagnostic tests that use the Cas12 and Cas13 CRISPR enzymes have already been put to the test as COVID-19 tests. Promisingly, these CRISPR diagnostic systems require readily-available reagents and can be used in paper-based lateral flow assays (similar to over-the-counter pregnancy tests), slashing both laboratory and patient costs significantly.

“Our development can quickly identify patients who have the virus, which is required to help address the ongoing threat to public health worldwide,” commented Hu.

Ultimately, the true value of the technology lies in how easy it is to use. “The sensitivity and simplicity of this test, its straightforward sample collection procedure, and the inexpensive nature of the readout device should permit the rapid translation of this approach to COVID-19 testing efforts once we obtain FDA approval,” Hu says.

 

Sources: Science Advances, Tulane University


 

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
OCT 07, 2022
Technology
App Uses Someone's Voice to Detect Parkinson's or Severe COVID-19
OCT 07, 2022
App Uses Someone's Voice to Detect Parkinson's or Severe COVID-19
Diagnosing health conditions can be particularly challenging. Oftentimes, diagnosis requires several different data poin ...
OCT 18, 2022
Cardiology
Type 2 Diabetes Prevention Requires Community Change
OCT 18, 2022
Type 2 Diabetes Prevention Requires Community Change
Preventing the rise of type 2 diabetes, obesity, and heart disease may require more than just medicine.
OCT 24, 2022
Neuroscience
Why is the Risk of Alzheimer's Higher in Women?
OCT 24, 2022
Why is the Risk of Alzheimer's Higher in Women?
Women tend to get Alzheimer's disease at a significantly higher rate than men; about two-thirds of people with the neuro ...
OCT 25, 2022
Cell & Molecular Biology
Liver Disease Discovery Resolves Controversy
OCT 25, 2022
Liver Disease Discovery Resolves Controversy
Liver diseases are a serious health problem. Chronic liver disease is estimated to impact over 1.5 billion people.
OCT 17, 2022
Clinical & Molecular DX
New Study Shows Biological Differences in the Second-Most Common Type of Breast Cancer
OCT 17, 2022
New Study Shows Biological Differences in the Second-Most Common Type of Breast Cancer
Though invasive lobular carcinoma (ILC) is the second-most common type of breast cancer, it has historically been resear ...
NOV 12, 2022
Coronavirus
Risk of Organ Failure & Death Rises with Repeated COVID-19 Infections
NOV 12, 2022
Risk of Organ Failure & Death Rises with Repeated COVID-19 Infections
After only a few months of the COVID-19 pandemic, scientists and clinicians knew that the virus could cause myriad healt ...
Loading Comments...